Clinical Trials
11
Active:0
Completed:10
Trial Phases
2 Phases
Phase 1:10
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (90.9%)Phase 2
1 (9.1%)Measurement of HTL0016878 in Cerebrospinal Fluid
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2021-04-19
- Lead Sponsor
- Heptares Therapeutics Limited
- Target Recruit Count
- 16
- Registration Number
- NCT04849286
- Locations
- 🇬🇧
MAC Clinical Research, Manchester, United Kingdom
Study to Investigate the Receptor Occupancy of HTL0014242 Using [18F] FPEB in Healthy Male Subjects
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2021-07-07
- Lead Sponsor
- Heptares Therapeutics Limited
- Target Recruit Count
- 8
- Registration Number
- NCT04462263
- Locations
- 🇬🇧
Parexel Early Phase Clinical Unit, Harrow, Middlesex, United Kingdom
Phase 1, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of mGlu5 NAM HTL0014242
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- Heptares Therapeutics Limited
- Target Recruit Count
- 71
- Registration Number
- NCT03785054
- Locations
- 🇬🇧
Covance, Leeds, West Yorkshire, United Kingdom
A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies
- First Posted Date
- 2018-07-19
- Last Posted Date
- 2019-10-01
- Lead Sponsor
- Heptares Therapeutics Limited
- Registration Number
- NCT03592862
- Locations
- 🇯🇵
Nishitaga Hospital, Sendai, Japan
🇯🇵Kagawa Prefectural Central Hospital, Takamatsu, Japan
🇯🇵Kurumi Clinic, Tokyo, Japan
Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care
- First Posted Date
- 2018-03-07
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- Heptares Therapeutics Limited
- Target Recruit Count
- 60
- Registration Number
- NCT03456349
- Locations
- 🇪🇸
Syneos, Barcelona, Spain
- Prev
- 1
- 2
- 3
- Next
News
No news found